Showing 2941-2950 of 5685 results for "".
- Congressional Briefing Discussing Safety of Contact Lenses as Regulated Medical Devices to be Held Tomorrowhttps://modernod.com/news/congressional-briefing-discussing-safety-of-contact-lenses-as-regulated-medical-devices-to-be-held-tomorrow/2480218/The Health Care Alliance for Patient Safety will hold a congressional briefing tomorrow, Tuesday, April 24, 2018, from noon-1 pm in The Rayburn House Office Building, Room 2247, in Washington DC, to discuss the importance of protecting the safety of patients who use contact lenses, which are regu
- Novartis Confirms 2018 Targets as Alcon Recovery Gains Steamhttps://modernod.com/news/novartis-confirms-2018-targets-as-alcon-recovery-gains-steam/2480224/Swiss drugmaker Novartis’ first quarterly results under new CEO Vas Narasimhan have been marred by a prized psoriasis treatment that disappointed and a sharp slump in sales by its U.S. generics unit, according to a
- Telemedicine Useful in Detecting Retinopathy of Prematurityhttps://modernod.com/news/telemedicine-useful-in-detecting-retinopathy-of-prematurity/2480230/Telemedicine has similar accuracy to ophthalmoscopy in detecting clinically significant retinopathy of prematurity (ROP), researchers say, according to a report in Reuters Health. “ROP is a leading cause of childhood blindness in the U.S. and throughout the world, yet it is often dif
- GlobalData: AI-Based Diabetic Retinopathy Device Can Reduce Burden on US Healthcare Systemhttps://modernod.com/news/globaldata-ai-based-diabetic-retinopathy-device-can-reduce-burden-on-us-healthcare-system/2480234/Iowa-based artificial intelligence (AI) diagnostics company IDx recently received market approval from the FDA for its AI-based medical device, IDx-DR, to detect greater than a mild level of diabetic retinopathy in adults. As the first of its kind to be authorized for commercialization, IDx-DR ha
- Alcon Introduces Preloaded Delivery System for the CyPass Micro-Stenthttps://modernod.com/news/alcon-introduces-preloaded-delivery-system-for-the-cypass-micro-stent/2480245/Alcon has announced the launch of the CyPass Ultra System designed to streamline the process of loading the CyPass Micro-Stent, a microinvasive glaucoma surgery (MIGS) device indicated for use in adult patients with mild-to-moderate primary open-angle glaucoma undergoing cataract surgery. The new
- Allergan Announces Official Launch of the TrueTear Intranasal Neurostimulation Devicehttps://modernod.com/news/allergan-announces-launch-of-the-truetear-intranasal-neurostimulation-device-at-ascrs/2480250/Allergan announced the official launch of TrueTear, the first and only FDA-cleared device developed to temporarily increase tear production during neurostimulation in adult patients. TrueTear, a handheld neurostimulation device with disposable tips that is inserted into the nasal cavity to
- FDA Approves Marketing For First AI Device for Diabetic Retinopathy Detectionhttps://modernod.com/news/fda-permits-marketing-of-ai-based-device-to-detect-certain-diabetes-related-eye-problems/2480256/The FDA has permitted marketing for the first medical device to use artificial intelligence to detect greater than a mild level of diabetic retinopathy in adults who have diabetes. The device, called IDx-DR, is a software program that uses an artificial intelligence algorithm to analyze im
- Veteran Business Development Executive Joins Lions Eye Institute as CMOhttps://modernod.com/news/veteran-business-development-executive-joins-lions-eye-institute-as-cmo/2480260/The Lions Eye Institute for Transplant & Research has announced the hiring of its first Chief Marketing Officer, Art Kurz, to strengthen the organization’s business development activities. Mr. Kurz, a former U.S. Air Force medic and graduate of Towson University, comes to Lions Eye Ins
- AMA Unveils New Policy Framework to Combat AI “Deepfake” Impersonation of Physicianshttps://modernod.com/news/ama-unveils-new-policy-framework-to-combat-ai-deepfake-impersonation-of-physicians/2487044/Key Takeaways The AMA has introduced a new policy framework aimed at protecting
- Sun Pharma to Acquire Organon in $11.75 Billion All-Cash Dealhttps://modernod.com/news/sun-pharma-to-acquire-organon-in-1175-billion-all-cash-deal/2486921/Key Takeaways